Komori
Linical (2183) · PolicyDecrease in dividend

Balancing Corporate Value Enhancement and Shareholder Returns

First written in FY2016. 10 of 27 entries say "Restated". Latest entry: FY2026.

27entries
11years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q1 – FY2024-Q22016: 320162017: 420172018: 220182019: 220192020: 220202021: 220212022: 120222023: 220232024: 220242025: 120252026: 62026
Same theme, other companies
Capital allocation policy balancing future investment and shareholder dividendsA theme 458 companies write about · 0 as a headwind · 460 as a tailwind

13 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 462 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Decrease in dividendAnnual report

    「For the dividend for the 21st fiscal year, the company paid a dividend of ¥8.00 per share in accordance with the policy described above.」

    The dividend per share decreased from ¥16 in the previous fiscal year to ¥8. The policy of balancing long-term corporate value enhancement with the return of profits to shareholders remains unchanged.
  2. FY2026-H1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 2 June 2025, the company resolved to pay dividends from retained earnings as follows.」

    For the dividend with a record date of 31 March 2025, the company paid total dividends of ¥361,382 thousand, or ¥16 per share. This was an increase from ¥15 per share in the previous fiscal year.
  3. FY2025-H1RestatedAnnual report

    「At a meeting of the Board of Directors held on 27 May 2024, the company resolved to pay dividends from retained earnings as follows.」

    For the dividend with a record date of 31 March 2024, the company paid total dividends of ¥338,796 thousand, or ¥15 per share. The increase from ¥14 per share in the previous fiscal year had already been disclosed in the immediately preceding full-year report, and this filing confirms its payment.
  4. FY2024AdvancedAnnual report

    「For the dividend for the 19th fiscal year, the company paid a dividend of ¥15 per share in accordance with the policy described above, resulting in a consolidated payout ratio of 100.2%.」

    The dividend per share increased from ¥14 in the previous fiscal year to ¥15, and the consolidated payout ratio was 100.2%.
  5. FY2024-Q2RestatedAnnual report

    「Board of Directors meeting, 29 May 2023 Common shares ¥316,210 thousand ¥14.00 31 March 2023 8 June 2023 Retained earnings」

    The company paid a dividend of ¥14 per share, totaling ¥316,210 thousand. This reconfirms the dividend results disclosed at the end of the previous fiscal year, with no change in the profit distribution policy.
  6. FY2024-Q1RestatedAnnual report

    「Board of Directors meeting, 29 May 2023 Common shares ¥316,210 thousand ¥14.00 31 March 2023 8 June 2023 Retained earnings」

    The company paid a dividend of ¥14 per share, totaling ¥316,210 thousand. The dividend per share was unchanged from the previous fiscal year, and no material change in the profit distribution policy was disclosed.
  7. FY2023-Q1RestatedAnnual report

    「At a meeting of the Board of Directors held on 30 May 2022, the following resolution was passed regarding the dividend from retained earnings.」

    For the dividend with a record date of 31 March 2022, the company paid ¥14 per share, totaling ¥316,210 thousand, on 9 June 2022. The dividend per share was unchanged from the previous fiscal year, with no material change in the profit distribution policy.
  8. FY2022-Q1RestatedAnnual report

    「At a meeting of the Board of Directors held on 31 May 2021, the company resolved to pay dividends from retained earnings as follows.」

    For the dividend with a record date of 31 March 2021, the company paid ¥14 per share, totaling ¥316,210 thousand. The dividend per share was unchanged from the previous fiscal year, and no material change in the profit distribution policy was disclosed.
  9. FY2021Dividend maintained; payout ratio decreasedAnnual report

    「For the dividend for the 16th fiscal year, the company paid a dividend of ¥14 per share in accordance with the policy described above, resulting in a consolidated payout ratio of 58.6%.」

    The dividend per share was maintained at ¥14, unchanged from the previous fiscal year, while the consolidated payout ratio declined from 65.5% to 58.6%.
  10. FY2021-Q1RestatedAnnual report

    「At a meeting of the Board of Directors held on 25 May 2020, the company resolved to pay dividends from retained earnings as follows.」

    The company paid a dividend of ¥14 per share, totaling ¥316,211 thousand, on 11 June 2020. This confirms the implementation of the dividend results disclosed at the end of the previous fiscal year, with no change in policy.
  11. FY2020AdvancedAnnual report

    「For the dividend for the 15th fiscal year, the company paid a dividend of ¥14 per share, including a ¥1 commemorative dividend marking the achievement of ¥10 billion in net sales, in accordance with the policy described above, resulting in a consolidated payout ratio of 65.5%.」

    The dividend per share increased from ¥12 in the previous fiscal year to ¥14, and the company paid a dividend with a consolidated payout ratio of 65.5%.
  12. FY2020-Q1RestatedAnnual report

    「At a meeting of the Board of Directors held on 27 May 2019, the company resolved to pay dividends from retained earnings as follows.」

    The company paid a dividend of ¥12 per share, totaling ¥271,038 thousand, with a record date of 31 March 2019. This reconfirms the dividend policy and results disclosed at the end of the previous fiscal year.
  13. FY2019AdvancedAnnual report

    「For the dividend for the 14th fiscal year, the company paid a dividend of ¥12 per share in accordance with the policy described above, resulting in a consolidated payout ratio of 47.8%.」

    The dividend increased from ¥11 per share and a consolidated payout ratio of 22.1% in the previous fiscal year to ¥12 per share and a consolidated payout ratio of 47.8% in the current fiscal year.
  14. FY2019-Q2RestatedAnnual report

    「Board of Directors meeting, 31 May 2018; common shares; ¥249,980 thousand; ¥11.00; 31 March 2018; 12 June 2018; retained earnings」

    The company paid a dividend of ¥11 per share, totaling ¥249,980 thousand, with a record date of 31 March 2018.
  15. FY2018AdvancedAnnual report

    「For the dividend for the 13th fiscal year, the company paid a dividend of ¥11 per share in accordance with the policy described above, resulting in a consolidated payout ratio of 22.1%.」

    The dividend increased from ¥10 per share and a payout ratio of 17.5% in the previous fiscal year to ¥11 per share and a consolidated payout ratio of 22.1%.
  16. FY2018-Q2RestatedAnnual report

    「Board of Directors meeting, 26 May 2017; common shares; ¥227,598 thousand; dividend per share: ¥10.00」

    The company paid a dividend of ¥10 per share, totaling ¥227,598 thousand, with a record date of 31 March 2017. This restates the dividend payment already reported in the previous quarterly report, with no change in policy.
  17. FY2018-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 26 May 2017, the company resolved to pay dividends from retained earnings as follows.」

    For the dividend with a record date of 31 March 2017, the company paid total dividends of ¥227,598 thousand, or ¥10 per share.
  18. FY2017AdvancedAnnual report

    「For the dividend for the 12th fiscal year, the company paid a dividend of ¥10 per share in accordance with the policy described above, resulting in a payout ratio of 17.5%.」

    In accordance with its policy of balancing medium- to long-term growth with the return of profits to shareholders, the company paid a dividend of ¥10 per share, with a payout ratio of 17.5%.
  19. FY2017-Q3RestatedAnnual report

    「This was mainly due to an increase in retained earnings from the recognition of quarterly net income attributable to owners of the parent, and a decrease in retained earnings from dividend payments.」

    The accumulation of profits and dividend payments are presented together, confirming that the company continues to strengthen its financial base through growth while returning profits to shareholders.
  20. FY2017-Q2AdvancedAnnual report

    「Cash used in financing activities during the six-month period ended ... amounted to ¥373 million (¥269 million used in the same period of the previous year). This was mainly due to ¥60 million in expenditures for the acquisition of treasury shares and ¥227 million in dividend payments.」

    The payment of ¥227 million in dividends was recorded as a financing activity for the six-month period, confirming that the company returned profits to shareholders.
  21. FY2017-Q1AdvancedAnnual report

    「At a meeting of the Board of Directors held on 30 May 2016, the Company resolved to pay dividends from retained earnings as follows.」

    The Company paid a dividend of ¥10 per share, comprising a regular dividend of ¥9 and a commemorative dividend of ¥1, representing a specific implementation of shareholder returns.
  22. FY2016First statedAnnual report

    「The Company regards optimizing the balance between enhancing corporate value through medium- to long-term growth and returning profits to shareholders as an important policy. From the perspective of how best to reward shareholders for the capital entrusted to the Company, it will pursue a dividend policy that takes performance into account and work to provide stable returns.」

    The policy is to balance investment for medium- to long-term growth with stable shareholder returns based on performance.
Moved together

"Global structure to support international joint clinical trials" moved the same way as this thread, in the same document, in 8 of its 27 moves.

875443★123456
  1. ★This thread
  2. 1Global structure to support international joint clinical trials8×
  3. 2Expansion into post-marketing drug development and differentiation7×
  4. 3Recruitment and development of talented CRAs5×
  5. 4LAA社 Order Intake Plan Shortfall and Underperformance4×
  6. 5Continued Expansion of Sales and Profit4×
  7. 6Shareholder Returns and Capital Policy through the Acquisition of Treasury Shares3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Linical yet. It last moved in the Financial results presentation materials of 2026-06-10: "Softened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Balancing Corporate Value Enhancement and Shareholder Returns | Linical Co.,Ltd. (2183) | Komori